Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Dr M James Barrett \"Jim\"
AddedMar 31, 2024
UpdatedMay 1, 2026
Dr M James Barrett \"Jim\"

Dr M James Barrett \"Jim\"

Board Member, Peptimmune

Dr M James Barrett \"Jim\"'s Career

Peptimmune
Peptimmune

Cambridge, MA, US

Board Member· Board
Predictive Biosciences
Predictive Biosciences

Lexington, KY, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Dr M James Barrett \"Jim\"'s Career

Peptimmune
Peptimmune
Series D$92.9M302002Cambridge, MA, US
Board Member· Board

Leadership at Peptimmune

Fredric PriceFredric PriceBoard Member
Luke EvninLuke EvninBoard Member

Similar to Peptimmune

InimmuneInimmuneMissoula, MT, USImmunotherapeuticsest. 2016InimmuneMissoula, MT, US · est. 2016

Inimmue: A cutting-edge biotech firm, pioneering next-gen immunotherapeutics.

Series A · $22.6M15
PeptiMedPeptiMedMadison, WI, USTherapeutic Drugsest. 2012PeptiMedMadison, WI, US · est. 2012

PeptiMed, Inc.: A biotech firm developing targeted therapeutic drugs for advanced cancers in the US.

Seed · $500k6
Petri BioPetri BioLos Angeles, CA, USTherapeuticsest. 2019Petri BioLos Angeles, CA, US · est. 2019

Petri Bio: A biotech firm innovating gut microbe-based therapeutics.

Seed · $255k3
IpiNovyx BioIpiNovyx BioWest Nyack, NY, USTherapeuticsest. 2021IpiNovyx BioWest Nyack, NY, US · est. 2021

IpiNovyx Bio: Pioneering immunoproteasome therapeutics for autoimmune and inflammatory diseases.

Seed · $10M6
Predictive Biosciences
Predictive Biosciences
Pre-Seed$68.1M752006Lexington, KY, US
Board Member· Board

Leadership at Predictive Biosciences

Bob LangerBob LangerBoard Member
Peter KlemmPeter KlemmCEO
Michael GreeleyMichael GreeleyBoard Member
MikeMikeBoard Member

Similar to Predictive Biosciences

Pbs-BioPbs-BioMesa, AZ, USCancer Treatment, Pharmaceutical Researchest. 2006Pbs-BioMesa, AZ, US · est. 2006

Arizona-based Predictive Biomarker Sciences develops innovative cancer treatment technologies for pharmaceutical research.

Angel · $338.1k6
Predictive Health Diagnostics CompanyPredictive Health Diagnostics CompanyIrvine, CA, USDiagnostic Testsest. 2017Predictive Health Diagnostics CompanyIrvine, CA, US · est. 2017

Predictive Health Diagnostics: Transforming data into intelligent, science-driven diagnostic tests.

Series A · $17.3M29
Castle BiosciencesCastle BiosciencesFriendswood, TX, USCancer Testsest. 2008Castle BiosciencesFriendswood, TX, US · est. 2008

Castle Biosciences, Inc.: A U.S. biotech firm offering diagnostic and prognostic cancer testing solutions.

Public · $354.3M543
PrevisePreviseBaltimore, MD, USBiomarker Testingest. 2018PreviseBaltimore, MD, US · est. 2018

Previse: Pioneering early cancer detection through affordable, accurate biomarker technology, starting with esophageal cancer.

Seed · $6.3M12

Dr M James Barrett \"Jim\"'s Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Dr M James Barrett \"Jim\"

James R Hackbarth \"Jim\"James R Hackbarth \"Jim\"Board Member · ProspXPhd BarrettPhd BarrettBoard Member · CogenesysJames L Carruthers Jr \"Jim\"James L Carruthers Jr \"Jim\"Board Member · Advanced BionutritionJames P Bradley \"Jim\"James P Bradley \"Jim\"Board Member · CureatrDr James Olson \"Jim\"Dr James Olson \"Jim\"Board Member · Blaze BioscienceJames W Mogg \"Jim\"James W Mogg \"Jim\"Board Member · Matrix Service